What they do
PostEra offers Manifold, an AI-powered platform that designs and optimizes synthesis routes for novel chemical compounds. Pharmaceutical companies and medicinal chemists use the software to evaluate compound synthesizability and accelerate the design-make-test-analyze cycle of small molecule drug discovery.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- AI drug discovery
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Boston, USA
- Region
- North America
- Founded
- 2019
- Total funding
- $26M raised
Notable investors: Bessemer Venture Partners, Playground Global, Outset Capital, Y Combinator.